カテゴリー： LP Information, 世界, 医療/バイオ

世界のオータコイド・関連薬市場予測 2021年-2026年

【英語タイトル】Global Autacoids and Related Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9433）・商品コード：LPI21MY9433
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：132
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「オータコイド・関連薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ポリペプチド、脱炭酸アミノ酸、エイコサノイドなど、用途別には、アレルギー、炎症、胃酸分泌、神経内分泌調節、慢性疼痛、心血管疾患、胃腸疾患などにセグメント区分してまとめました。オータコイド・関連薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・オータコイド・関連薬の世界市場概要（サマリー）
・オータコイド・関連薬の企業別販売量・売上
・オータコイド・関連薬の企業別市場シェア
・オータコイド・関連薬の世界市場規模 2016年-2021年：種類別（ポリペプチド、脱炭酸アミノ酸、エイコサノイド）
・オータコイド・関連薬の世界市場規模 2016年-2021年：用途別（アレルギー、炎症、胃酸分泌、神経内分泌調節、慢性疼痛、心血管疾患、胃腸疾患）
・オータコイド・関連薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・オータコイド・関連薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・オータコイド・関連薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・オータコイド・関連薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・オータコイド・関連薬市場の成長要因・課題・動向
・オータコイド・関連薬の世界市場予測 2021年-2026年
・オータコイド・関連薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・オータコイド・関連薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・オータコイド・関連薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・オータコイド・関連薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・オータコイド・関連薬の世界市場予測：種類別（ポリペプチド、脱炭酸アミノ酸、エイコサノイド）
・オータコイド・関連薬の世界市場予測：用途別（アレルギー、炎症、胃酸分泌、神経内分泌調節、慢性疼痛、心血管疾患、胃腸疾患）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Autacoids and Related Drugs will have significant change from previous year. By the most conservative estimates of global Autacoids and Related Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Autacoids and Related Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Autacoids and Related Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Polypeptides
Decarboxylated Amino Acids
Eicosanoids

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Allergies
Inflammation
Gastric Acid Secretion
Neuroendocrine Regulation
Chronic Pain
Cardiovascular Diseases
Gastrointestinal Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bedford Laboratories
Bristol-Myers Squibb
APP Pharma
Abbott Laboratories
Sanofi
Chattem
Xanodyne
AstraZeneca
Hospira

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autacoids and Related Drugs Consumption 2016-2026
2.1.2 Autacoids and Related Drugs Consumption CAGR by Region
2.2 Autacoids and Related Drugs Segment by Type
2.2.1 Polypeptides
2.2.2 Decarboxylated Amino Acids
2.2.3 Eicosanoids
2.3 Autacoids and Related Drugs Sales by Type
2.3.1 Global Autacoids and Related Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Autacoids and Related Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Autacoids and Related Drugs Sale Price by Type (2016-2021)
2.4 Autacoids and Related Drugs Segment by Application
2.4.1 Allergies
2.4.2 Inflammation
2.4.3 Gastric Acid Secretion
2.4.4 Neuroendocrine Regulation
2.4.5 Chronic Pain
2.4.6 Cardiovascular Diseases
2.4.7 Gastrointestinal Diseases
2.5 Autacoids and Related Drugs Sales by Application
2.5.1 Global Autacoids and Related Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Autacoids and Related Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Autacoids and Related Drugs Sale Price by Application (2016-2021)

3 Global Autacoids and Related Drugs by Company
3.1 Global Autacoids and Related Drugs Sales Market Share by Company
3.1.1 Global Autacoids and Related Drugs Sales by Company (2019-2021)
3.1.2 Global Autacoids and Related Drugs Sales Market Share by Company (2019-2021)
3.2 Global Autacoids and Related Drugs Revenue Market Share by Company
3.2.1 Global Autacoids and Related Drugs Revenue by Company (2019-2021)
3.2.2 Global Autacoids and Related Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Autacoids and Related Drugs Sale Price by Company
3.4 Global Manufacturers Autacoids and Related Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autacoids and Related Drugs Product Location Distribution
3.4.2 Players Autacoids and Related Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Autacoids and Related Drugs by Region
4.1 Global Autacoids and Related Drugs by Region
4.1.1 Global Autacoids and Related Drugs Sales by Region
4.1.2 Global Autacoids and Related Drugs Revenue by Region
4.2 Americas Autacoids and Related Drugs Sales Growth
4.3 APAC Autacoids and Related Drugs Sales Growth
4.4 Europe Autacoids and Related Drugs Sales Growth
4.5 Middle East & Africa Autacoids and Related Drugs Sales Growth

5 Americas
5.1 Americas Autacoids and Related Drugs Sales by Country
5.1.1 Americas Autacoids and Related Drugs Sales by Country (2016-2021)
5.1.2 Americas Autacoids and Related Drugs Revenue by Country (2016-2021)
5.2 Americas Autacoids and Related Drugs Sales by Type
5.3 Americas Autacoids and Related Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Autacoids and Related Drugs Sales by Region
6.1.1 APAC Autacoids and Related Drugs Sales by Region (2016-2021)
6.1.2 APAC Autacoids and Related Drugs Revenue by Region (2016-2021)
6.2 APAC Autacoids and Related Drugs Sales by Type
6.3 APAC Autacoids and Related Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Autacoids and Related Drugs by Country
7.1.1 Europe Autacoids and Related Drugs Sales by Country (2016-2021)
7.1.2 Europe Autacoids and Related Drugs Revenue by Country (2016-2021)
7.2 Europe Autacoids and Related Drugs Sales by Type
7.3 Europe Autacoids and Related Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Autacoids and Related Drugs by Country
8.1.1 Middle East & Africa Autacoids and Related Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Autacoids and Related Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Autacoids and Related Drugs Sales by Type
8.3 Middle East & Africa Autacoids and Related Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Autacoids and Related Drugs Distributors
10.3 Autacoids and Related Drugs Customer

11 Global Autacoids and Related Drugs Market Forecast
11.1 Global Autacoids and Related Drugs Forecast by Region
11.1.1 Global Autacoids and Related Drugs Forecast by Regions (2021-2026)
11.2.2 Global Autacoids and Related Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Autacoids and Related Drugs Forecast by Type
11.7 Global Autacoids and Related Drugs Forecast by Application

12 Key Players Analysis
12.1 Bedford Laboratories
12.1.1 Bedford Laboratories Bedford Laboratories Company Information
12.1.2 Bedford Laboratories Autacoids and Related Drugs Product Offered
12.1.3 Bedford Laboratories Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bedford Laboratories Main Business Overview
12.1.5 Bedford Laboratories Latest Developments
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Information
12.2.2 Bristol-Myers Squibb Autacoids and Related Drugs Product Offered
12.2.3 Bristol-Myers Squibb Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Bristol-Myers Squibb Main Business Overview
12.2.5 Bristol-Myers Squibb Latest Developments
12.3 APP Pharma
12.3.1 APP Pharma Company Information
12.3.2 APP Pharma Autacoids and Related Drugs Product Offered
12.3.3 APP Pharma Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 APP Pharma Main Business Overview
12.3.5 APP Pharma Latest Developments
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Information
12.4.2 Abbott Laboratories Autacoids and Related Drugs Product Offered
12.4.3 Abbott Laboratories Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Abbott Laboratories Main Business Overview
12.4.5 Abbott Laboratories Latest Developments
12.5 Sanofi
12.5.1 Sanofi Company Information
12.5.2 Sanofi Autacoids and Related Drugs Product Offered
12.5.3 Sanofi Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sanofi Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Chattem
12.6.1 Chattem Company Information
12.6.2 Chattem Autacoids and Related Drugs Product Offered
12.6.3 Chattem Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Chattem Main Business Overview
12.6.5 Chattem Latest Developments
12.7 Xanodyne
12.7.1 Xanodyne Company Information
12.7.2 Xanodyne Autacoids and Related Drugs Product Offered
12.7.3 Xanodyne Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Xanodyne Main Business Overview
12.7.5 Xanodyne Latest Developments
12.8 AstraZeneca
12.8.1 AstraZeneca Company Information
12.8.2 AstraZeneca Autacoids and Related Drugs Product Offered
12.8.3 AstraZeneca Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 AstraZeneca Main Business Overview
12.8.5 AstraZeneca Latest Developments
12.9 Hospira
12.9.1 Hospira Company Information
12.9.2 Hospira Autacoids and Related Drugs Product Offered
12.9.3 Hospira Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Hospira Main Business Overview
12.9.5 Hospira Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Autacoids and Related Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Polypeptides
Table 3. Major Players of Decarboxylated Amino Acids
Table 4. Major Players of Eicosanoids
Table 5. Global Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units)
Table 6. Global Autacoids and Related Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Autacoids and Related Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Autacoids and Related Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Autacoids and Related Drugs Sale Price by Type (2016-2021)
Table 10. Global Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units)
Table 11. Global Autacoids and Related Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Autacoids and Related Drugs Value by Application (2016-2021)
Table 13. Global Autacoids and Related Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Autacoids and Related Drugs Sale Price by Application (2016-2021)
Table 15. Global Autacoids and Related Drugs Sales by Company (2019-2021) & (K Units)
Table 16. Global Autacoids and Related Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Autacoids and Related Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Autacoids and Related Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Autacoids and Related Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Autacoids and Related Drugs Producing Area Distribution and Sales Area
Table 21. Players Autacoids and Related Drugs Products Offered
Table 22. Autacoids and Related Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Autacoids and Related Drugs Sales by Region (2016-2021) (K Units)
Table 26. Global Autacoids and Related Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Autacoids and Related Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Autacoids and Related Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units)
Table 30. Americas Autacoids and Related Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Autacoids and Related Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Autacoids and Related Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units)
Table 34. Americas Autacoids and Related Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units)
Table 36. Americas Autacoids and Related Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Autacoids and Related Drugs Sales by Region (2016-2021) & (K Units)
Table 38. APAC Autacoids and Related Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Autacoids and Related Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Autacoids and Related Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units)
Table 42. APAC Autacoids and Related Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units)
Table 44. APAC Autacoids and Related Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units)
Table 46. Europe Autacoids and Related Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Autacoids and Related Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Autacoids and Related Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units)
Table 50. Europe Autacoids and Related Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units)
Table 52. Europe Autacoids and Related Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Autacoids and Related Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Autacoids and Related Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Application (2016-2021)
Table 61. Global Autacoids and Related Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Autacoids and Related Drugs Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Autacoids and Related Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Autacoids and Related Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Autacoids and Related Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Autacoids and Related Drugs Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Autacoids and Related Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Autacoids and Related Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 69. Bedford Laboratories Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 70. Bedford Laboratories Autacoids and Related Drugs Product Offered
Table 71. Bedford Laboratories Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 72. Bedford Laboratories Main Business
Table 73. Bedford Laboratories Latest Developments
Table 74. Bristol-Myers Squibb Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Bristol-Myers Squibb Autacoids and Related Drugs Product Offered
Table 76. Bristol-Myers Squibb Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 77. Bristol-Myers Squibb Main Business
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. APP Pharma Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. APP Pharma Autacoids and Related Drugs Product Offered
Table 81. APP Pharma Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 82. APP Pharma Main Business
Table 83. APP Pharma Latest Developments
Table 84. Abbott Laboratories Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Abbott Laboratories Autacoids and Related Drugs Product Offered
Table 86. Abbott Laboratories Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 87. Abbott Laboratories Main Business
Table 88. Abbott Laboratories Latest Developments
Table 89. Sanofi Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi Autacoids and Related Drugs Product Offered
Table 91. Sanofi Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 92. Sanofi Main Business
Table 93. Sanofi Latest Developments
Table 94. Chattem Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Chattem Autacoids and Related Drugs Product Offered
Table 96. Chattem Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 97. Chattem Main Business
Table 98. Chattem Latest Developments
Table 99. Xanodyne Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Xanodyne Autacoids and Related Drugs Product Offered
Table 101. Xanodyne Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 102. Xanodyne Main Business
Table 103. Xanodyne Latest Developments
Table 104. AstraZeneca Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. AstraZeneca Autacoids and Related Drugs Product Offered
Table 106. AstraZeneca Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 107. AstraZeneca Main Business
Table 108. AstraZeneca Latest Developments
Table 109. Hospira Basic Information, Autacoids and Related Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Hospira Autacoids and Related Drugs Product Offered
Table 111. Hospira Autacoids and Related Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 112. Hospira Main Business
Table 113. Hospira Latest Developments
List of Figures
Figure 1. Picture of Autacoids and Related Drugs
Figure 2. Autacoids and Related Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autacoids and Related Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Autacoids and Related Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Autacoids and Related Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Polypeptides
Figure 10. Product Picture of Decarboxylated Amino Acids
Figure 11. Product Picture of Eicosanoids
Figure 12. Global Autacoids and Related Drugs Sales Market Share by Type in 2020
Figure 13. Global Autacoids and Related Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Autacoids and Related Drugs Consumed in Allergies
Figure 15. Global Autacoids and Related Drugs Market: Allergies (2016-2021) & (K Units)
Figure 16. Autacoids and Related Drugs Consumed in Inflammation
Figure 17. Global Autacoids and Related Drugs Market: Inflammation (2016-2021) & (K Units)
Figure 18. Autacoids and Related Drugs Consumed in Gastric Acid Secretion
Figure 19. Global Autacoids and Related Drugs Market: Gastric Acid Secretion (2016-2021) & (K Units)
Figure 20. Autacoids and Related Drugs Consumed in Neuroendocrine Regulation
Figure 21. Global Autacoids and Related Drugs Market: Neuroendocrine Regulation (2016-2021) & (K Units)
Figure 22. Autacoids and Related Drugs Consumed in Chronic Pain
Figure 23. Global Autacoids and Related Drugs Market: Chronic Pain (2016-2021) & (K Units)
Figure 24. Autacoids and Related Drugs Consumed in Cardiovascular Diseases
Figure 25. Global Autacoids and Related Drugs Market: Cardiovascular Diseases (2016-2021) & (K Units)
Figure 26. Autacoids and Related Drugs Consumed in Gastrointestinal Diseases
Figure 27. Global Autacoids and Related Drugs Market: Gastrointestinal Diseases (2016-2021) & (K Units)
Figure 28. Global Autacoids and Related Drugs Sales Market Share by Application (2016-2021)
Figure 29. Global Autacoids and Related Drugs Revenue Market Share by Application in 2020
Figure 30. Global Autacoids and Related Drugs Revenue Market by Company in 2020 ($ Million)
Figure 31. Global Autacoids and Related Drugs Revenue Market Share by Company in 2020
Figure 32. Global Autacoids and Related Drugs Sales Market Share by Regions (2016-2021)
Figure 33. Global Autacoids and Related Drugs Revenue Market Share by Region in 2020
Figure 34. Americas Autacoids and Related Drugs Sales 2016-2021 (K Units)
Figure 35. Americas Autacoids and Related Drugs Revenue 2016-2021 ($ Millions)
Figure 36. APAC Autacoids and Related Drugs Sales 2016-2021 (K Units)
Figure 37. APAC Autacoids and Related Drugs Revenue 2016-2021 ($ Millions)
Figure 38. Europe Autacoids and Related Drugs Sales 2016-2021 (K Units)
Figure 39. Europe Autacoids and Related Drugs Revenue 2016-2021 ($ Millions)
Figure 40. Middle East & Africa Autacoids and Related Drugs Sales 2016-2021 (K Units)
Figure 41. Middle East & Africa Autacoids and Related Drugs Revenue 2016-2021 ($ Millions)
Figure 42. Americas Autacoids and Related Drugs Sales Market Share by Country in 2020
Figure 43. Americas Autacoids and Related Drugs Revenue Market Share by Country in 2020
Figure 44. Americas Autacoids and Related Drugs Sales Market Share by Type in 2020
Figure 45. Americas Autacoids and Related Drugs Sales Market Share by Application in 2020
Figure 46. United States Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Canada Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Mexico Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Brazil Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. APAC Autacoids and Related Drugs Sales Market Share by Region in 2020
Figure 51. APAC Autacoids and Related Drugs Revenue Market Share by Regions in 2020
Figure 52. APAC Autacoids and Related Drugs Sales Market Share by Type in 2020
Figure 53. APAC Autacoids and Related Drugs Sales Market Share by Application in 2020
Figure 54. China Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Japan Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Korea Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Southeast Asia Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. India Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Australia Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Europe Autacoids and Related Drugs Sales Market Share by Country in 2020
Figure 61. Europe Autacoids and Related Drugs Revenue Market Share by Country in 2020
Figure 62. Europe Autacoids and Related Drugs Sales Market Share by Type in 2020
Figure 63. Europe Autacoids and Related Drugs Sales Market Share by Application in 2020
Figure 64. Germany Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. France Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. UK Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Italy Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Russia Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Country in 2020
Figure 70. Middle East & Africa Autacoids and Related Drugs Revenue Market Share by Country in 2020
Figure 71. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Type in 2020
Figure 72. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Application in 2020
Figure 73. Egypt Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. South Africa Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Israel Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 76. Turkey Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 77. GCC Country Autacoids and Related Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles


★調査レポート[世界のオータコイド・関連薬市場予測 2021年-2026年] (コード：LPI21MY9433)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオータコイド・関連薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の自己投与薬市場予測 2021年-2026年
    LPI21MY9572 / LP Information / 2021年5月 / LPインフォメーション社の「自己投与薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、注射薬、吸入薬、経皮吸収薬など、用途別には、心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他などにセグメント区分してまとめました。自己投与薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・自己投与薬の世界市場概要（サマリー） ・自己投与薬の企業別販売量・売上 ・自己投与薬の企業別市場シェア ・自己投与薬の世界市場規模 2016年-2021年：種類別（注射薬、吸入薬、経皮吸収薬） ・自己投与薬の世界市場規模 2016年-2021年：用途別（心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他） ・自己投与薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・自己投与薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Self-administered Drugs will have significant change from previous year. By the most conservative estimates of global Self-administered Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Self-administered Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Self-administered Drugs market by product type, application, key manufacturers and...
  • 世界の抗片頭痛薬市場予測 2021年-2026年
    LPI21MY9422 / LP Information / 2021年5月 / LPインフォメーション社の「抗片頭痛薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、トリプタン、麦角、その他など、用途別には、女性、男性などにセグメント区分してまとめました。抗片頭痛薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗片頭痛薬の世界市場概要（サマリー） ・抗片頭痛薬の企業別販売量・売上 ・抗片頭痛薬の企業別市場シェア ・抗片頭痛薬の世界市場規模 2016年-2021年：種類別（トリプタン、麦角、その他） ・抗片頭痛薬の世界市場規模 2016年-2021年：用途別（女性、男性） ・抗片頭痛薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗片頭痛薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Migraine Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Migraine Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-Migraine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Migraine Drugs market by product type, application, key manufacturers and...
  • 世界のイマチニブ薬市場予測 2021年-2026年
    LPI21MY9644 / LP Information / 2021年5月 / LPインフォメーション社の「イマチニブ薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カプセル、錠剤など、用途別には、病院、ドラッグストア、その他などにセグメント区分してまとめました。イマチニブ薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・イマチニブ薬の世界市場概要（サマリー） ・イマチニブ薬の企業別販売量・売上 ・イマチニブ薬の企業別市場シェア ・イマチニブ薬の世界市場規模 2016年-2021年：種類別（カプセル、錠剤） ・イマチニブ薬の世界市場規模 2016年-2021年：用途別（病院、ドラッグストア、その他） ・イマチニブ薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・イマチニブ薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Imatinib Drugs will have significant change from previous year. By the most conservative estimates of global Imatinib Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Imatinib Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Drugs market by product type, application, key manufacturers and...
  • 世界の鎮咳薬市場予測 2021年-2026年
    LPI21MY9425 / LP Information / 2021年5月 / LPインフォメーション社の「鎮咳薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、中枢作用性鎮咳薬、局所作用性鎮咳薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。鎮咳薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・鎮咳薬の世界市場概要（サマリー） ・鎮咳薬の企業別販売量・売上 ・鎮咳薬の企業別市場シェア ・鎮咳薬の世界市場規模 2016年-2021年：種類別（中枢作用性鎮咳薬、局所作用性鎮咳薬） ・鎮咳薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・鎮咳薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・鎮咳薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antitussive Drugs will have significant change from previous year. By the most conservative estimates of global Antitussive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antitussive Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antitussive Drugs market by product type, application, key manufacturers and...
  • 世界の獣医痛み管理薬市場予測 2021年-2026年
    LPI21MY9684 / LP Information / 2021年5月 / LPインフォメーション社の「獣医痛み管理薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、オピオイド、α2-アドレナリン作動薬、局所麻酔薬、非ステロイド性抗炎症薬（NSID）、鎮静剤、コルチコステロイド、その他など、用途別には、獣医病院、獣医クリニック、小売用などにセグメント区分してまとめました。獣医痛み管理薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・獣医痛み管理薬の世界市場概要（サマリー） ・獣医痛み管理薬の企業別販売量・売上 ・獣医痛み管理薬の企業別市場シェア ・獣医痛み管理薬の世界市場規模 2016年-2021年：種類別（オピオイド、α2-アドレナリン作動薬、局所麻酔薬、非ステロイド性抗炎症薬（NSID）、鎮静剤、コルチコステロイド、その他） ・獣医痛み管理薬の世界市場規模 2016年-2021年：用途別（獣医病院、獣医クリニック、小売用） ・獣医痛み管理薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・獣医痛み管理薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Veterinary Pain Management Drugs will have significant change from previous year. By the most conservative estimates of global Veterinary Pain Management Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Veterinary Pain Management Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Pain Management Drugs...
  • 世界の高脂血症処方薬市場予測 2021年-2026年
    LPI21MY9642 / LP Information / 2021年5月 / LPインフォメーション社の「高脂血症処方薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、HMG COAレダクターゼ阻害剤、ibフィブリン酸誘導体、ニコチン酸、胆汁酸封鎖剤、コレステロール吸収阻害剤、併用薬物療法など、用途別には、病院、クリニックなどにセグメント区分してまとめました。高脂血症処方薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・高脂血症処方薬の世界市場概要（サマリー） ・高脂血症処方薬の企業別販売量・売上 ・高脂血症処方薬の企業別市場シェア ・高脂血症処方薬の世界市場規模 2016年-2021年：種類別（HMG COAレダクターゼ阻害剤、ibフィブリン酸誘導体、ニコチン酸、胆汁酸封鎖剤、コレステロール吸収阻害剤、併用薬物療法） ・高脂血症処方薬の世界市場規模 2016年-2021年：用途別（病院、クリニック）...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Hyperlipidemia Prescription Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Hyperlipidemia Prescription Drugs market by product type,...
  • 世界の降圧薬市場予測 2021年-2026年
    LPI21MY9420 / LP Information / 2021年5月 / LPインフォメーション社の「降圧薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。降圧薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・降圧薬の世界市場概要（サマリー） ・降圧薬の企業別販売量・売上 ・降圧薬の企業別市場シェア ・降圧薬の世界市場規模 2016年-2021年：種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬） ・降圧薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・降圧薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・降圧薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Hypertensive Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Hypertensive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 39390 million in 2019. Over the next five years the Anti-Hypertensive Drugs market will register a 1.7% CAGR in terms of revenue, the global market size will reach US$ 42110 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Hypertensive Drugs market by product type, application, key manufacturers and...
  • 世界の抗消化性潰瘍薬市場予測 2021年-2026年
    LPI21MY9411 / LP Information / 2021年5月 / LPインフォメーション社の「抗消化性潰瘍薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬など、用途別には、胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）などにセグメント区分してまとめました。抗消化性潰瘍薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗消化性潰瘍薬の世界市場概要（サマリー） ・抗消化性潰瘍薬の企業別販売量・売上 ・抗消化性潰瘍薬の企業別市場シェア ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬） ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・抗消化性潰瘍薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗消化性潰瘍薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Peptic Ulcer Drugs...
  • 世界のオキシコドン塩酸塩治療薬市場予測 2021年-2026年
    LPI21MY9614 / LP Information / 2021年5月 / LPインフォメーション社の「オキシコドン塩酸塩治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、経口液剤、経口カプセル、静脈内輸液など、用途別には、病院、診療所、その他などにセグメント区分してまとめました。オキシコドン塩酸塩治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・オキシコドン塩酸塩治療薬の世界市場概要（サマリー） ・オキシコドン塩酸塩治療薬の企業別販売量・売上 ・オキシコドン塩酸塩治療薬の企業別市場シェア ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：種類別（錠剤、経口液剤、経口カプセル、静脈内輸液） ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：用途別（病院、診療所、その他） ・オキシコドン塩酸塩治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・オキシコドン塩酸塩治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Oxycodone Hydrochloride Drugs will have significant change from previous year. By the most conservative estimates of global Oxycodone Hydrochloride Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oxycodone Hydrochloride Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Drugs market by product type,...
  • 世界の神経内分泌がん治療薬市場予測 2021年-2026年
    LPI21MY9603 / LP Information / 2021年5月 / LPインフォメーション社の「神経内分泌がん治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ソマトスタチン類似体、標的療法、化学療法など、用途別には、病院、クリニック、腫瘍学センター、外来手術センターなどにセグメント区分してまとめました。神経内分泌がん治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・神経内分泌がん治療薬の世界市場概要（サマリー） ・神経内分泌がん治療薬の企業別販売量・売上 ・神経内分泌がん治療薬の企業別市場シェア ・神経内分泌がん治療薬の世界市場規模 2016年-2021年：種類別（ソマトスタチン類似体、標的療法、化学療法） ・神経内分泌がん治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、腫瘍学センター、外来手術センター） ・神経内分泌がん治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・神経内分泌がん治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Neuroendocrine Carcinoma Drugs will have significant change from previous year. By the most conservative estimates of global Neuroendocrine Carcinoma Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Neuroendocrine Carcinoma Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Neuroendocrine Carcinoma Drugs market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆